share_log
Moomoo 24/7 ·  03/19 09:05

Cerus Corporation Shares Are Trading Higher After the Company Announced Its ReCePI Phase 3 Trial of INTERCEPT Blood System Met Its Primary Efficacy Endpoint

Cerus Corporation宣布其INTERCEPT血液系统的Recepi三期试验达到其主要疗效终点后,该公司股价走高

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发